The Impact of a Physical Activity Intervention Can be Accurately Assessed By Smart Watches in Patients Completing Autologous Stem Cell Transplantation for Lymphoma or Multiple Myeloma: Results of a Feasibility Study
Conclusion: Our findings support the feasibility of studying an inpatient PA intervention for ASCT pts using traditional and novel methods. Nearly 70% of pts who participated were successful in adhering to a PA regimen of 150 minutes of exercise. Ongoing assessment by research staff to encourage pts to adhere to prescribed exercise, as well as use of a smart watch to validate PA by HR data was feasible. QoL results are consistent with prior PA studies in ASCT pts, with no significant decrease in overall QoL by day +30. Additional analyses from this study, including a flow-based panel to measure the impact of PA on immune reconstitution post ASCT, will be presented at the meeting. We plan to utilize the findings from this feasibility study to construct a randomized study of PA in ASCT assessing QoL as a primary outcome.DisclosuresCalzada: Seattle Genetics: Research Funding. Nooka: Janssen pharmaceuticals: Consultancy, Membership on an entity's Board of Directors or advisory committees; Takeda: Consultancy, Membership on an entity's Board of Directors or advisory committees; GSK: Consultancy, Membership on an entity's Board of Directors or advisory committees; Celgene: Consultancy, Membership on an entity's Board of Directors or advisory committees; Adaptive technologies: Consultancy, Membership on an entity's Board of Directors or advisory committees; Spectrum Pharmaceuticals: Consultancy, Membership on an entity's Board of Directors or advisory committees; BMS: Consultancy, M...
Source: Blood - Category: Hematology Authors: Ip, A., Churnetski, M. C., Calzada, O., Chang, A., Liu, Y., Bumpers, N., Leeson, D., Mahar, E., Hesaroieh, I., Crain, M., Nooka, A. K., Koff, J. L., Hofmeister, C. C., Gupta, V. A., Allen, P., Lechowicz, M. J., Kaufman, J. L., Blum, K. A., Lonial, S., Lan Tags: 904. Outcomes Research-Malignant Conditions Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Genetics | Heart | Heart Transplant | History of Medicine | Hodgkin's Disease | Lymphoma | Merck | Myeloma | Non-Hodgkin's Lymphoma | Sports Medicine | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants